Pancreatic Cancer Research

ResearcherJiangsu Province HospitalActive in the last 2 years

Xiaofeng Xue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0963-7994; OpenAlex author ID A5050762332. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 3 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 12

  1. Circulating inflammatory indices refine prognostic stratification and complication risk in pancreatic cancer following radical surgery. Co-author DOI 10.21037/gs-2026-1-0008↗
  2. Retraction Note: hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. First author DOI 10.1038/s41416-025-03268-y↗
  3. An interpretable machine learning model for predicting early liver metastasis after pancreatic cancer surgery. Co-author DOI 10.1186/s12885-025-14503-3↗
  4. Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner. Co-author DOI 10.4143/crt.2022.1600↗
  5. Risk factors and survival prediction of pancreatic cancer with lung metastases: A population-based study. Last author DOI 10.3389/fonc.2022.952531↗
  6. A CARE-compliant case report: total pancreatectomy and total gastrectomy to treat pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/md.0000000000018151↗
  7. Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial-mesenchymal transition via Hedgehog signaling pathway. First author DOI 10.1002/cam4.1752↗
  8. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/ijc.27715↗
  9. MAP3K10 promotes the proliferation and decreases the sensitivity of pancreatic cancer cells to gemcitabine by upregulating Gli-1 and Gli-2. Co-author DOI 10.1016/j.canlet.2012.11.005↗
  10. CEACAM6 induces epithelial-mesenchymal transition and mediates invasion and metastasis in pancreatic cancer. Co-author DOI 10.3892/ijo.2013.2015↗
  11. High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreat… Co-author DOI 10.1002/ijc.26290↗
  12. Galectin-1 secreted by activated stellate cells in pancreatic ductal adenocarcinoma stroma promotes proliferation and invasion of pancreatic cancer cells: an i… Co-author DOI 10.1097/mpa.0b013e318217945e↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junyi Qiu · 2 shared papers, 2025–2026 · strength 0.63
  2. Jiayue Zou · 1 shared paper, 2026 · strength 0.39
  3. Jie J. Yao · 3 shared papers, 2011–2025 · strength 0.29
  4. Tingting Feng · 1 shared paper, 2024 · strength 0.26
  5. Pei Cao · 1 shared paper, 2024 · strength 0.26
  6. Ding Sun · 1 shared paper, 2025 · strength 0.25
  7. Hao Zhu · 1 shared paper, 2025 · strength 0.25
  8. Fei Wang · 1 shared paper, 2025 · strength 0.24
  9. Miao Yi · 1 shared paper, 2025 · strength 0.24
  10. Jia Wei · 1 shared paper, 2025 · strength 0.24
  11. Zong-Xi Yao · 1 shared paper, 2022 · strength 0.19
  12. Lei Qin · 2 shared papers, 2018–2019 · strength 0.18
  13. Yong An · 5 shared papers, 2011–2013 · strength 0.15
  14. Jishu Wei · 5 shared papers, 2011–2013 · strength 0.15
  15. Kuirong Jiang · 4 shared papers, 2011–2013 · strength 0.11
  16. Dong Tang · 4 shared papers, 2011–2013 · strength 0.11
  17. Yanghui Wen · 1 shared paper, 2019 · strength 0.10
  18. Xiaolan Xu · 1 shared paper, 2019 · strength 0.10
  19. Haixin Qian · 1 shared paper, 2019 · strength 0.10
  20. Qiang Li · 3 shared papers, 2011–2013 · strength 0.09
  21. Wentao Gao · 3 shared papers, 2011–2013 · strength 0.09
  22. Junli Wu · 3 shared papers, 2011–2013 · strength 0.09
  23. Zipeng Lu · 3 shared papers, 2011–2013 · strength 0.08
  24. Yi Miao · 3 shared papers, 2011–2013 · strength 0.08
  25. Ye Zhang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.